Foghorn Therapeutics Inc. Common Stock (FHTX) is a publicly traded Healthcare sector company. As of May 21, 2026, FHTX trades at $4.00 with a market cap of $224.29M and a P/E ratio of -3.34. FHTX moved +11.25% today. Year to date, FHTX is -19.68%; over the trailing twelve months it is -3.38%. Its 52-week range spans $2.94 to $9.99. Analyst consensus is strong buy with an average price target of $11.60. Rallies surfaces FHTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
FHTX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. FHTX recently traded at $4.00. Market cap is $224.29M. P/E ratio is -3.34. Revenue is $28.22M.
| Metric | Value |
|---|---|
| Price | $4.00 |
| Market Cap | $224.29M |
| P/E Ratio | -3.34 |
| EPS | $-1.16 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.99 |
| 52-Week Low | $2.94 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $28.22M |
| Net Income | $-75.32M |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $30.91M | $-74.28M | $-1.18 |
| 2024 | $22.60M | $-86.62M | $-1.58 |
| 2023 | $34.16M | $-98.43M | $-2.34 |
| 2022 | $19.23M | $-108.88M | $-2.62 |
6 analysts cover FHTX: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $11.60.